Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$2.2B
Avg Funding
$89.1M
Cities
19

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Boston, United States
$200.0M
raised

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Hayward, United States
$250.0M
raised

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Watertown, United States
$450.0M
raised

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$7.2M
raised

OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$50.0M
raised

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$25.0M
raised

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Antonio, United States
$4.0M
raised

BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Paris, France
$1.1M
raised

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$110.0M
raised

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miramar Beach, United States
$1.5M
raised

HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cincinnati, United States
$12.9M
raised

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bromma, Sweden
$3.1M
raised

OncoZenge develops better products for the supportive care of cancer patients.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$1.2M
raised

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States
$4.0M
raised

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$2.5M
raised

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Morgan Hill, United States
$2.9M
raised

Tenon Medical is a biotechnology company that optimizes SI joint surgical solutions.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$50.0M
raised

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$380.0M
raised

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$5.7M
raised

NAIA Relief Inc is a health tech company that offers a mental health platform driven by AI.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$393K
raised

New treatment for blood diseases, such as leukemia and lymphoma.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United Kingdom
$3.7M
raised

EDX Medical Group provides innovative digital diagnostic products and services.

Aug 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Würzburg, Germany
$23.2M
raised

Pentixapharm develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$23.5M
raised

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$375.1M
raised

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$240.0M
raised

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked